Janna Kingston

Authored by Lindsay Bayes

Character Biography

Eyes: Green
Hair: Blond, curly

Place of Birth:
Mother: Sara Kingston

Born: 24 February, 2360; Heliopolis, Alpha Eridani II

2382- Completes Bachelors degree in Exobiology and Psychology (double major) at Heliopolis University.
2385- Cadet Cruise on USS Hypatia. Injured during this and develops a mild form of haemophilia (see medical notes)
2386- Attends Starfleet Medical Academy and completes Masters degree in Clinical Psychology. Completed internship on Alpha Centauri and graduated with the rank of Lieutenant Junior Grade.
2387- Assigned to Outpost 45 as Junior Counsellor while working on PhD.
2390- Completes PhD in Clinical Psychology.
2392- Reassigned to USS Athena as an Assistant Counsellor.

Her diminutive statute and easy manner often disguise her very sharp and cunning mind, but people who get to know her better soon come to see her as a deeply complex woman. Janna’s well known hobby is ‘people-watching’ but often for more than simple clinical purposes. She finds people genuinely fascinating and is generally able to read them well. Having worked in varied environments, she has a great deal experience with different species and is rarely fazed by the ‘new’.

Medical File

Janna was on the USS Hypatia as a cadet on her training cruise. They were on a survey mission out in the Zeta Gelis Cluster and made contact with a people known as the Rankarii of Emiria III.

While on the planet, Janna and a small team were investigating an unusual report from the locals about a semi-sentient vine they called ‘lako’. For several days they found no evidence, but Janna came into contact with the lako vine rather unexpectedly near a cave. It attacked her immune system and liver, resulting in damage to her clotting Factor V gene.

The medical staff on the Hypatia conducted gene therapy to correct the issue and it seemed at first to have worked. But after 18 months, the treatment began to reverse itself. They have repeated the gene treatment but each time it reverses itself withing 1-2 years.

Therefore, Janna is technically diagnosed with aprahaemophilia. A prophylactic (regularly scheduled) treatment regimen with the appropriate clotting factors and specific exercises to strengthen joints reduces the complications of bleeds. Janna’s case is considered mild (clotting factors are at 40% of normal) and usually non-life threatening. While a permanent treatment is always hoped for, so far nothing seems to have worked for currently unknown reasons.